Navigation Links
Bay Area Women Sought for Egg Freezing Study
Date:9/28/2007

Reproductive Science Center of the San Francisco Bay research seeks couples

with male factor infertility

SAN RAMON, Calif., Sept. 28 /PRNewswire/ -- Reproductive Science Center of the San Francisco Bay Area, in cooperation with ViaCell, Inc., has been awarded a research grant to evaluate the safety and effectiveness of ViaCyte, an investigational product intended to broaden reproductive options for women through freezing and thawing of human eggs (oocytes). RSC's IVF and Medical Director Dr. Louis Weckstein is the principal clinical investigator.

The study seeks couples with male factor infertility who want to achieve pregnancy. Female participants must be healthy, between the ages of 21 and 35, and must not have had more than one previous miscarriage or more than one failed in vitro fertilization (IVF) attempt. The couple must be willing to undergo egg retrieval with an egg freeze and thaw, after which they will undergo intracytoplasmic sperm injection (ICSI) and embryo transfer in order to achieve pregnancy. Women enrolling in this study will have their procedures performed at RSC and should anticipate a time commitment of approximately 12-months (three to four months for a standard IVF cycle, cryopreservation and thaw of oocytes, embryo transfer, and up to nine months for the resulting pregnancy follow-up). There is no cost to any enrolled patients for their treatment in the course of this study.

Human oocyte cryopreservation or egg freezing has been investigated since the 1980's and has been used experimentally in certain IVF populations, in women who are undergoing cancer treatments who are at risk of losing their fertility, and in women choosing to preserve their fertility. There is currently no FDA-cleared product offered for oocyte cryopreservation. For more information regarding the study, please visit http://www.rscbayarea.com or call 925.973.5012.

About Reproductive Science Center

Established in 1983, the Reproductive Science Center of the San Francisco Bay Area was one of the earliest IVF facilities in the United States, begun just two years after the nation's first successful IVF treatment. RSC was among the first in the United States to report a successful pregnancy from an egg donated from one woman to another for gestation and delivery, and was also responsible for the nation's second successful transfer of a previously frozen embryo into a mother's uterus. Today, RSC boasts a staff of six infertility physicians with a collective 85 years' experience with offices in San Ramon, Orinda, San Jose, Fremont, Modesto, Brentwood, and Monterey. The Reproductive Science Center is a member of IntegraMed, a national network of 30 fertility centers in 95 locations across the United States. Nearly one of every four IVF procedures in the United States is performed in an IntegraMed practice. For more information, visit http://www.rscbayarea.com. Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Dr. Louis Weckstein http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=58599


'/>"/>
SOURCE Reproductive Science Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
2. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
5. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
6. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
9. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
10. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
11. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 A ReportsnReports.com report says, over the ... as the global sales of Adcetris and Kadcyla have been witnessing ... drug conjugates market is driven by large number of ADC drugs ... window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 Major Company Profiles, ...
(Date:3/24/2017)... YORK , March 24, 2017 ... and Equipment stocks, which are: Neovasc Inc. (NASDAQ: NVCN), Hologic ... Heart Inc. (NASDAQ: SSH ). These companies are ... its prior gains on Thursday, March 23 rd , 2017, ... afternoon, while shares of health care companies in the S&P ...
(Date:3/24/2017)... 24, 2017  GenomeDx Biosciences today announced that six ... Decipher® Prostate Cancer Classifier tests will be presented at ... (EAU) Congress held March 24 to 28, 2017 in ... Congress is Europe,s largest urological ... the urological field. The abstract titled "Muscle ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier provider ... caring for those suffering from the full spectrum of disordered eating, announced today that ... professionals from nearly all 50 states and several countries converged on the Green Valley ...
(Date:3/24/2017)... ... March 24, 2017 , ... In just ... EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone ... with nearly 2,000 consumers (and counting) already backing the campaign. , “We ...
(Date:3/24/2017)... ... 24, 2017 , ... On June 9, 2017, Cassie Springer ... seminar in Chicago, Illinois. She will present on: , Filing Benefit Claims—Responding ... ERISA involve claims for long-term disability benefits. This session will address the ...
(Date:3/24/2017)... ... 2017 , ... Gastro Health (“GH”) ( http://www.gastrohealth.com ) ... colonoscopy at the HyGIeaCare® Center that is to be located adjacent to the ... The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration (FDA), will ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ Through Social ... devotional journal chronicling the writer’s path toward true communion with God. “Finding Christ ... #TruthwithGrace” is the creation of published author Lea Michelle Johnson, a follower of ...
Breaking Medicine News(10 mins):